COVID-19: Testing Landscape Post-Infection, -Vaccination, and Future Perspectives

Area of Science:

• Infectious Diseases
• Immunology
• Diagnostic Medicine

Background:

• The COVID-19 pandemic, declared in March 2020, highlighted the need for robust diagnostic tools.
• Molecular testing is the gold standard for diagnosing COVID-19.
• Serological testing offers insights into immune responses and community transmission.

Purpose of the Study:

• To review and analyze the current landscape of SARS-CoV-2 testing in the United States.
• To provide guidance on the appropriate use of direct pathogen detection and serological testing.
• To explore the monitoring of humoral and cellular immunity post-infection and vaccination.

Main Methods:

• Literature review and analysis of current SARS-CoV-2 diagnostic strategies in the US.
• Examination of guidelines for utilizing molecular and serological tests.
• Assessment of methods for evaluating immune responses.

Main Results:

• Molecular testing remains crucial for acute COVID-19 diagnosis.
• Serological tests are valuable for assessing immune status and population-level spread.
• Monitoring both humoral and cellular immunity provides a comprehensive view of patient response.

Conclusions:

• Effective SARS-CoV-2 testing strategies require a combination of molecular and serological approaches.
• Understanding immune responses is key for managing infection and vaccination.
• Ongoing adaptation of diagnostics is necessary to address viral evolution and future public health needs.